psychedelic science

Psychedelic Research Company Developing Sustainably-Grown Peyote in Canada

Lophos Pharmaceuticals Corp. is a Canadian psychedelic research company focused on peyote and its derivatives such as mescaline. Peyote, an endangered plant species with a long history of therapeutic use, has legal status in Canada, but mescaline, a powerful psychedelic molecule derived from the plant, remains a Schedule 3 controlled substance. At their facility, Lophos Pharma …

Psychedelic Research Company Developing Sustainably-Grown Peyote in Canada Read More »

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness

By Raley Anne James According to a mental health organization, one in five adults in the U.S. experience having a mental illness each year. These include serious mental health conditions such as anxiety disorders, major depressive episodes, and post-traumatic stress disorder. Despite the various organizations trying to counter these issues to increase mental health awareness and …

Using Psychoactive Plants and Fungi for Long-Term Mental Wellness Read More »

Queen’s University Health Sciences to Launch Psychedelics Research Collaborative

The Faculty of Health Sciences at Queen’s University will create a research collaborative that will serve as an interdisciplinary space for research, innovation and knowledge translation in the field of psychedelics. The launch of the psychedelics research collaborative is enabled by the Dimensions Health Fund in support of the Study of Psychedelics, established by Dimensions Health …

Queen’s University Health Sciences to Launch Psychedelics Research Collaborative Read More »

New UCSF Research Program to Advance Psychedelics Research and Treatments

Psychedelics research in support of brain health is getting a major boost this month with the formation of the Neuroscape Psychedelics Division at the University of California, San Francisco (UCSF). Through $6.4M in private funding, the new division will take a unique translational research approach to integrate cutting-edge neuroscience technology with psychedelics treatment, including through …

New UCSF Research Program to Advance Psychedelics Research and Treatments Read More »

Psychedelic Science Holds Promise for Mainstream Medicine

UNLV Neuroscientists’ Work on Brain Activity Recently Published by Nature: Scientific Reports Psychedelic healing may sound like a fad from the Woodstock era, but it’s a field of study that’s gaining traction in the medical community as an effective treatment option for a growing number of mental health conditions. While the study of psychedelics as medicine …

Psychedelic Science Holds Promise for Mainstream Medicine Read More »

Mount Sinai Health System Launches Center for Psychedelic Research

The Icahn School of Medicine at Mount Sinai has launched a new center for psychedelics research. The Center for Psychedelic Psychotherapy and Trauma Research pursues a multipronged clinical and research approach to discovering novel and more efficacious therapies for post-traumatic stress disorder (PTSD), depression, anxiety, and other stress-related conditions in the veteran and civilian population. The Center …

Mount Sinai Health System Launches Center for Psychedelic Research Read More »

MDMA-Assisted Psychotherapy May Reduce Anxiety for Those Diagnosed with Life-Threatening Illness

Future Clinical Trials With Larger Sample Sizes and More Diverse Populations Are Warranted to Study the Application of MDMA-Assisted Psychotherapy for Treating Anxiety A peer-reviewed study published today in the journal Scientific Reports provides sufficient evidence to support further research into the palliative effects of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. The pilot study, sponsored …

MDMA-Assisted Psychotherapy May Reduce Anxiety for Those Diagnosed with Life-Threatening Illness Read More »

Study Shows Psychedelic Treatment with Psilocybin Relieves Major Depression

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up. A compound found in so-called …

Study Shows Psychedelic Treatment with Psilocybin Relieves Major Depression Read More »

Scroll to Top